A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
Condition: Erosive EsophagitisInterventions: Drug: Dexlansoprazole; Drug: PlaceboSponsor: TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials
A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
Condition: Gastroesophageal RefluxIntervention: Drug: DexlansoprazoleSponsor: TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials
A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
Condition: Erosive EsophagitisInterventions: Drug: Dexlansoprazole; Drug: PlaceboSponsor: TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials
A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
Condition: Gastroesophageal RefluxIntervention: Drug: DexlansoprazoleSponsor: TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials
A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
Condition: Erosive EsophagitisInterventions: Drug: Dexlansoprazole; Drug: PlaceboSponsor: TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials
Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection
Condition: Helicobacter Pylori InfectionInterventions: Drug: dexlansoprazole based triple therapy; Drug: rabeprazole-based triple therapySponsor: Kaohsiung Medical UniversityCompleted - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2015 Category: Research Source Type: clinical trials
